FDA Panel Backs 2 Hepatitis C Drugs
Links shared publicly online about this topic.
- 331total visits
FDA Panel Backs 2 Hepatitis C Drugs
View full resource at webmd.com
Tags: Liver Condition, Hepatitis, Hepatitis C, Hepatitis C Medication, Drug, FDA, Telaprevir
Most Recently Shared on April 29, 2011 at 12:51 am By:
FDA Panel Backs 2 Hepatitis C Drugs: A major advance for treating hepatitis C is likely headed to market after g... http://bit.ly/l3CzdU
Also Shared By:
UPDATE: FDA Panel Backs Approval Of Vertex's Hepatitis C Drug - FoxNews.com
foxnews.com — “A Food and Drug Administration panel unanimously backed the approval of Vertex Pharmaceuticals Inc.'s proposed hepatitis C-drug telaprevir, saying it showed strong effectiveness, a day after also endorsing a similar product from Merck & Co.” View full resource at foxnews.com
Most Recently Shared on April 29, 2011 at 7:54 pm By:
Health,Fitness,Diet Health Business
UPDATE: FDA Panel Backs Approval Of Vertex's Hepatitis C Drug http://bit.ly/iSysXD
Hepatitis drugs: Boceprevir, telaprevir get FDA panels approval - latimes.com
latimes.com — “Two new hepatitis C drugs got unanimous backing from an FDA advisory panel this week” View full resource at latimes.com
Most Recently Shared on April 29, 2011 at 7:28 pm By:
LA Times Health News Health News
Advisory panel likes new hepatitis C drugs, which could expand options http://lat.ms/levTrT
HCV New Drug Research: FDA Panel Backs Approval Of Telaprevir For Hepatitis C
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: FDA Panel Backs Approval Of Telaprevir For Hepatitis C” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 28, 2011 at 8:16 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
FDA Panel Backs Approval Of Telaprevir For Hepatitis C http://goo.gl/fb/Vc4n9
Merck Wins U.S. FDA Panel--™s Backing for Hepatitis C Drug - Bloomberg
bloomberg.com — “Merck & Co. won a U.S. panel--™s backing to sell an experimental hepatitis C drug that cured more patients in clinical trials than current therapies.” View full resource at bloomberg.com
Most Recently Shared on April 28, 2011 at 11:20 am By:
John Carroll Health Communicator
In case you missed it, Merck gets unanimous panel support on boceprevir; list of suggested post-marketing studies. http://bloom.bg/iwYpxP
FDA panel backs Merck hepatitis drug | Reuters
reuters.com — “SILVER SPRING, Maryland (Reuters) - A Merck & Co drug that boosts the chance of curing hepatitis C infection moved closer to the U.S. market on Wednesday as an advisory panel unanimously recommended” View full resource at reuters.com
Most Recently Shared on April 27, 2011 at 8:31 pm By:
Bruce McLucas, MD Surgeon, Physician, Doctor, and ObGyn Physician
US FDA panel backs Merck hepatitis drug http://ow.ly/1cn94b
FDA panel backs Merck hepatitis drug | Reuters
reuters.com — “SILVER SPRING, Maryland (Reuters) - A Merck & Co drug that boosts the chance of curing hepatitis C infection moved closer to the U.S. market on Wednesday as an advisory panel unanimously recommended” View full resource at reuters.com
Most Recently Shared on April 27, 2011 at 8:17 pm By:
US FDA panel backs Merck hepatitis drug http://reut.rs/m9ERc1
FDA panel backs Merck hepatitis drug | Reuters
in.reuters.com — “SILVER SPRING, Maryland (Reuters) - A Merck & Co drug that boosts the chance of curing hepatitis C infection moved closer to the U.S. market on Wednesday as an advisory panel unanimously recommended” View full resource at in.reuters.com
Most Recently Shared on April 27, 2011 at 8:11 pm By:
eyeonfda Pharma and Health Lawyer
RT @rtrsin_health: US FDA panel backs Merck hepatitis drug http://reut.rs/lrHJnz
FDA panel backs Merck hepatitis drug
health.yahoo.net — “A Merck & Co drug that boosts the chance of curing hepatitis C infection moved closer to the U.S. market on Wednesday as an advisory panel unanimously recommended approval.” View full resource at health.yahoo.net
Most Recently Shared on April 27, 2011 at 4:00 pm By:
Jane Anderson Healthy Eating Advisor
Merck pitches hepatitis C drug to U.S. FDA panel http://bit.ly/fhOHAn
FDA panel backs Merck hepatitis drug
health.yahoo.net — “A Merck & Co drug that boosts the chance of curing hepatitis C infection moved closer to the U.S. market on Wednesday as an advisory panel unanimously recommended approval.” View full resource at health.yahoo.net
Most Recently Shared on April 27, 2011 at 3:39 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Merck pitches hepatitis C drug to U.S. FDA panel: An experimental drug for the liver-damaging hepatitis C virus ... http://bit.ly/g2QI1D
Hepatitis C New Drug Research
hepatitiscnewdrugresearch.com — “Keep Updated On Boceprevir” View full resource at hepatitiscnewdrugresearch.com
Most Recently Shared on March 14, 2011 at 6:10 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Updated Hepatitis C;Telaprevir,Boceprevir http://shar.es/3OAtF
Summary Box: FDA panel backs use of anemia drugs
health.yahoo.net — “VOTE OF CONFIDENCE: A Food and Drug Administration panel of medical experts voted overwhelmingly to allow anemia drugs from Amgen Inc. to remain approved for patients with kidney disease, despite a recent study showing the injectable treatments can increase the risk of stroke.” View full resource at health.yahoo.net
Most Recently Shared on October 18, 2010 at 9:37 pm By:
Jane Anderson Healthy Eating Advisor
Summary Box: FDA panel backs use of anemia drugs http://bit.ly/c2rlA3
Advertisement
WebMD_News
@WebMD_News
FDA Panel Backs 2 Hepatitis C Drugs: A major advance for treating hepatitis C is likely headed to market after g... http://bit.ly/l3CzdU
1 year ago...